POLARx™ Cardiac Cryoablation System Post Market Clinical Study (POLAR SMART)

CompletedOBSERVATIONAL
Enrollment

295

Participants

Timeline

Start Date

August 26, 2022

Primary Completion Date

October 29, 2024

Study Completion Date

October 29, 2024

Conditions
Paroxysmal Atrial Fibrillation
Interventions
DEVICE

Boston Scientific Cardiac Cryoablation System

is indicated for cryoablation and electrical mapping of the pulmonary veins for pulmonary vein isolation (PVI) in the ablation treatment of AF as per current and future guidelines and system IFU/ Tenpubunsyo.

Trial Locations (19)

466-8650

Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya

036-8563

Hirosaki University Hospital, Hirosaki-shi

260-8677

Chiba University Hospital, Chiba

802-8555

Kokura Memorial Hospital, Kitakyushu-shi

247-0072

Shonan Kamakura General Hospital, Kamakura-shi

231-8682

Yokohama City Minato Red Cross Hospital, Yokohama

238-8558

Yokosuka Kyosai Hospital, Yokosuka-shi

606-8507

Kyoto University Hospital, Kyoto

880-2102

Miyazaki Medical Association Hospital, Miyazaki

564-8565

National Cerebral and Cardiovascular Center Hospital, Suita-shi

330-8553

Saitama Red Cross Hospital, Saitama

431-3192

Hamamatsu University Hospital, Hamamatsu

113-8519

Medical Hospital, Tokyo Medical and Dental University, Bunkyo-ku

183-0003

Sakakibara Heart Institute, Fuchu-shi

190-0014

National Hospital Organization Disaster Medical Center, Tachikawa-shi

Unknown

Kobe City Medical Center General Hospital, Kobe

Kobe University Hospital, Kobe

05030

Konkuk University Medical Center, Seoul

06351

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY